Literature DB >> 21135819

Half-century-old TB drugs get a facelift in new cocktails.

Stu Hutson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21135819     DOI： 10.1038/nm1210-1346b

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  1 in total

1.  The Mycobacterium tuberculosis drugome and its polypharmacological implications.

Authors:  Sarah L Kinnings; Li Xie; Kingston H Fung; Richard M Jackson; Lei Xie; Philip E Bourne
Journal:  PLoS Comput Biol       Date:  2010-11-04       Impact factor: 4.475
  1 in total
  2 in total

1.  Impact of Fgd1 and ddn diversity in Mycobacterium tuberculosis complex on in vitro susceptibility to PA-824.

Authors:  Silke Feuerriegel; Claudio U Köser; Davide Baù; Sabine Rüsch-Gerdes; David K Summers; John A C Archer; Marc A Marti-Renom; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

Review 2.  Delivery of host cell-directed therapeutics for intracellular pathogen clearance.

Authors:  Michael A Collier; Matthew D Gallovic; Kevin J Peine; Anthony D Duong; Eric M Bachelder; John S Gunn; Larry S Schlesinger; Kristy M Ainslie
Journal:  Expert Rev Anti Infect Ther       Date:  2013-10-18       Impact factor: 5.091
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.